VivoSeq
Other

Extracellular Vesicles

0

Pipeline Programs↗

2

Active Trials↗

3

Companies Involved↗

Extracellular Vesicles is an early-stage landscape with 0 programs across 3 companies. The most active players are Aegle Therapeutics, United Therapeutics, Direct Biologics, LLC.

Intelligence

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

50/100

Attrition Rate

25/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

A

Aegle Therapeutics

0 programs

PreclinicalUnited Therapeutics logo

United Therapeutics

0 programs

PreclinicalD

Direct Biologics, LLC

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

8

clinical trials

Recruiting2 · 25%
Completed2 · 25%
Unknown status2 · 25%
Terminated1 · 13%
Withdrawn1 · 13%

Clinical Trials

Trial Activity

8 trials

Use of Extracellular Vesicles (EV) for Knee Osteoarthrosis
Recruiting·UUniversity of Jordan·Phase 1·NCT06937528·50 enrolled
Exploring Nasal Drop Therapy With Small Extracellular Vesicles for ALS
Recruiting·XXuanwu Hospital, Beijing·Phase 1/2·NCT06598202·38 enrolled
Safety of Extracellular Vesicles for Burn Wounds
Completed·AAegle Therapeutics·Phase 1·NCT05078385·1 enrolled
Safety Evaluation of Intracoronary Infusion of Extracellular Vesicles in Patients Following Coronary Stent Implantation
Completed·—·Phase 1·NCT04327635·9 enrolled
A Safety Study of IV Stem Cell-derived Extracellular Vesicles (UNEX-42) in Preterm Neonates at High Risk for BPD
Terminated·United Therapeutics logoUnited Therapeutics·Phase 1·NCT03857841·3 enrolled
Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles Infusion Treatment for ARDS
Withdrawn·DDirect Biologics, LLC·Phase 1/2·NCT05127122
Use of Autologous Plasma Rich in Platelets and Extracellular Vesicles in the Surgical Treatment of Chronic Middle Ear Infections
Unknown status·UUniversity Medical Centre Ljubljana·Phase 2/3·NCT04761562·100 enrolled
Extracellular Vesicles and Endothelial Function in Transgender Subjects
Unknown status·—·N/A·NCT04971447·136 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)